JNCE

Jounce Therapeutics, Inc. Common Stock
JNCE

Overview Fund Activity
Delisted

JNCE was delisted on the 3rd of May, 2023.

Back to rankings

130 hedge funds and large institutions have $243M invested in Jounce Therapeutics, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 65 increasing their positions, 24 reducing their positions, and 14 closing their positions.

Holders
130
Holders Change
+6
Holders Change %
+4.84%
% of All Funds
2.27%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
20
Increased
65
Reduced
24
Closed
14
Calls
$340K
Puts
$1.73M
Net Calls
-$1.39M
Net Calls Change
+$1.24M

Top Buyers

1
Assenagon Asset Management
1
Assenagon Asset Management
Luxembourg
$4.64M
2
BlackRock
2
BlackRock
New York
$16.7M
3
CS
3
Candriam SCA
Luxembourg
$2.29M
4
O
4
OrbiMed
New York
$14.6M
5
Millennium Management
5
Millennium Management
New York
$3.12M

Top Sellers

1
TGI
1
TRV GP II
Massachusetts
$30.2M
2
Victory Capital Management
2
Victory Capital Management
Texas
$3.3M
3
CCM
3
CAAS Capital Management
New York
$0
4
ACA
4
Avoro Capital Advisors
New York
$0
5
ACM
5
Asymmetry Capital Management
California
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Two Sigma Investments
26
Two Sigma Investments
New York
$2.02M +$1.38M +202,780 +214%
OFM
27
Omega Fund Management
Massachusetts
$1.87M – – –
HM
28
HealthCor Management
New York
$1.82M +$447K +65,710 +32%
Charles Schwab
29
Charles Schwab
California
$1.76M +$395K +58,069 +29%
Marshall Wace
30
Marshall Wace
United Kingdom
$1.71M +$1.07M +156,739 +165%
Two Sigma Advisers
31
Two Sigma Advisers
New York
$1.48M +$917K +134,800 +163%
T. Rowe Price Associates
32
T. Rowe Price Associates
Maryland
$1.26M +$308K +45,232 +32%
Goldman Sachs
33
Goldman Sachs
New York
$1.12M +$88.7K +13,038 +9%
AQR Capital Management
34
AQR Capital Management
Connecticut
$1.06M +$52K +7,657 +5%
Nuveen Asset Management
35
Nuveen Asset Management
Illinois
$1.06M +$203K +29,838 +24%
Mariner
36
Mariner
Kansas
$1.02M +$394 +58 +0%
Wells Fargo
37
Wells Fargo
California
$985K -$666K -98,043 -40%
Renaissance Technologies
38
Renaissance Technologies
New York
$906K +$775K +113,990 +590%
SSA
39
Schonfeld Strategic Advisors
New York
$885K -$536K -78,800 -38%
Jacobs Levy Equity Management
40
Jacobs Levy Equity Management
New Jersey
$863K -$7.67K -1,128 -0.9%
Bank of New York Mellon
41
Bank of New York Mellon
New York
$695K +$211K +31,097 +44%
PAM
42
Panagora Asset Management
Massachusetts
$631K +$622K +91,500 +6,693%
Morgan Stanley
43
Morgan Stanley
New York
$617K +$502K +73,775 +435%
D.E. Shaw & Co
44
D.E. Shaw & Co
New York
$537K +$537K +78,923 New
Qube Research & Technologies (QRT)
45
Qube Research & Technologies (QRT)
United Kingdom
$524K +$400K +58,877 +323%
First Trust Advisors
46
First Trust Advisors
Illinois
$495K +$89.1K +13,103 +22%
Connor, Clark & Lunn Investment Management (CC&L)
47
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$494K -$85.7K -12,599 -15%
ZCM
48
Ziegler Capital Management
Illinois
$483K +$483K +71,097 New
Squarepoint
49
Squarepoint
New York
$435K +$353K +51,891 +430%
AllianceBernstein
50
AllianceBernstein
Tennessee
$421K +$40.8K +6,000 +11%
1
2
3 4 5